Marketing-authorisation holder · Cyprus
Remedica Ltd.
6 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Cyprus
6 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abakavir/lamivudin Remedica 600 mg/300 mg filmom obložene tablete*filmom obložena tableta | Abacavir, Lamivudine | Croatia | Not marketed | 2022 |
| Emtricitabin/tenofovirdizoproksil Remedica 200 mg/245 mg filmom obložene tablete*filmom obložena tableta | Emtricitabine, Tenofovir disoproxil | Croatia | Not marketed | 2022 |
| Lenvatinib Remedica 10 mg, harde capsulesCapsule, hard | Lenvatinib | Netherlands | Authorised | 2025 |
| Lenvatinib Remedica 10 mg tvrde kapsuleKapsula, tvrda | Lenvatinib | Croatia | Not marketed | 2025 |
| Lenvatinib Remedica 4 mg, harde capsulesCapsule, hard | Lenvatinib | Netherlands | Authorised | 2025 |
| Lenvatinib Remedica 4 mg tvrde kapsuleKapsula, tvrda | Lenvatinib | Croatia | Not marketed | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.